Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Phillip

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Vascular Cell|May 28, 2015
Solenopsin A and analogs exhibit ceramide-like biological activityIsabella Karlsson, Xin Zhou, Raquela Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgeryRichard W Light, Jeffrey T Rogers, J Phillip Moyers, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 14, 2016
Breastfeeding and maternal alcohol use: Prevalence and effects on child outcomes and fetal alcohol spectrum disordersPhilip A May, Julie M Hasken, Jason Blankenship, et al.
Leukemia|June 25, 2026
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse eventsAnthony G Mansour, Ying Huang, J Phillip Pemberton, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in ratsCarrie K Jones, Ashley E Brady, Albert A Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learningJana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Environment International|September 3, 2022
Use of systematic evidence maps within the US environmental protection agency (EPA) integrated risk information system (IRIS) program: Advancements to date and looking aheadKristina A Thayer, Rachel M Shaffer, Michelle Angrish, et al.
Environmental Health Perspectives|February 6, 2024
Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health DashboardAvanti V Shirke, Elizabeth G Radke, Cynthia Lin, et al.
Environmental Health Perspectives|May 17, 2022
Systematic Evidence Map for Over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS)Laura M Carlson, Michelle Angrish, Avanti V Shirke, et al.
Environmental Health Perspectives|January 10, 2024
Erratum: "Systematic Evidence Map for over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS)"Laura M Carlson, Michelle Angrish, Avanti V Shirke, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Vascular Cell|May 28, 2015
Solenopsin A and analogs exhibit ceramide-like biological activityIsabella Karlsson, Xin Zhou, Raquela Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgeryRichard W Light, Jeffrey T Rogers, J Phillip Moyers, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 14, 2016
Breastfeeding and maternal alcohol use: Prevalence and effects on child outcomes and fetal alcohol spectrum disordersPhilip A May, Julie M Hasken, Jason Blankenship, et al.
Leukemia|June 25, 2026
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse eventsAnthony G Mansour, Ying Huang, J Phillip Pemberton, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in ratsCarrie K Jones, Ashley E Brady, Albert A Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learningJana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Environment International|September 3, 2022
Use of systematic evidence maps within the US environmental protection agency (EPA) integrated risk information system (IRIS) program: Advancements to date and looking aheadKristina A Thayer, Rachel M Shaffer, Michelle Angrish, et al.
Environmental Health Perspectives|February 6, 2024
Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health DashboardAvanti V Shirke, Elizabeth G Radke, Cynthia Lin, et al.
Environmental Health Perspectives|May 17, 2022
Systematic Evidence Map for Over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS)Laura M Carlson, Michelle Angrish, Avanti V Shirke, et al.
Environmental Health Perspectives|January 10, 2024
Erratum: "Systematic Evidence Map for over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS)"Laura M Carlson, Michelle Angrish, Avanti V Shirke, et al.
Pageof 26